FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:222-224 January 16, 1997 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Vongpatanasin, W. PubMed Citation

To the Editor: In their review of prosthetic heart valves, Vongpatanasin et al. (Aug. 8 issue)¹ propose guidelines for anticoagulant therapy after valve implantation without citing references to support them. The authors make the surprising recommendation that patients with mechanical valves receive anticoagulant therapy "preferably within 6 to 12 hours" after valve implantation. If this recommendation refers to warfarin, how is it administered? If it refers to heparin, then the patient is at risk for bleeding during this period, given the fact that platelets are nonfunctioning after weaning from cardiopulmonary bypass. It is unclear how best to deal with the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Walther, T., Walther, C., Falk, V., Diegeler, A., Krakor, R., Schneider, J., Autschbach, R., Mohr, F. W. (1999). Early Clinical Results After Stentless Mitral Valve Implantation and Comparison With Conventional Valve Repair or Replacement. Circulation 100: II-78-83 [Abstract] [Full Text]